SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001367920-16-000025
Filing Date
2016-04-25
Accepted
2016-04-25 08:58:29
Documents
3
Period of Report
2016-06-09
Effectiveness Date
2016-04-25

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2016proxy.htm DEF 14A 574332
2 concertpharmaceuticalsin001.jpg GRAPHIC 118832
3 concertpharmaceuticalsin002.jpg GRAPHIC 105822
  Complete submission text file 0001367920-16-000025.txt   880375
Mailing Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 500 LEXINGTON MA 02421 781-860-0045
CONCERT PHARMACEUTICALS, INC. (Filer) CIK: 0001367920 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36310 | Film No.: 161587974
SIC: 2834 Pharmaceutical Preparations